Teva- Pharmaceutical Industries Ltd vs United Therapeutics Corp

Teva- Pharmaceutical Industries Ltd (TEVA) is overvalued and United Therapeutics Corp (UTHR) is fairly valued.

Against our estimates of intrinsic value, UTHR trades at the wider discount: a margin of safety of +2%, against -110% for TEVA.

Values as of the 17 Nov 2026 close.

Teva- Pharmaceutical Industries Ltd (TEVA)

Discounting its cash flows at 9.7% (average of 3 methods) values the shares at $20.28; the price of $42.62 is 110% above that value, and 73% of that value comes from beyond year five.

Leak Score: free with an account

United Therapeutics Corp (UTHR)

Discounting its cash flows at 8.2% (average of 3 methods) values the shares at $596.66; the price of $584.10 is 2% below that value, and 79% of that value comes from beyond year five.

Leak Score: free with an account

MetricTEVAUTHR
VerdictOvervaluedFairly valued
Price$42.62$584.10
Intrinsic value$20.28$596.66
Margin of safety-110%+2%
Market cap$49.7B$24.9B
Revenue growth, 5 years0.8%16.5%
Operating margin19.2%43.6%
Net margin2.9%38.6%
Return on equity6.7%19.1%
Debt to equity2.130.00
P/E100.3x22.0x
Forward P/E13.7x19.6x
P/B6.2x3.9x

All stocks in Drug Manufacturers - Specialty & Generic